|
|
Suppliers for
Rapastinel
|
Properties | CAS |
117928-94-6 | Formula |
C18H31N5O6 |
|
|
1 Registered suppliers
Description : Rapastinel, a brain penetrable tetrapeptide, could be a partial agonist of NMDA receptor. It was already finished the Phase II trial for acting as an antidepressant agent. It was just planed a phase III trial for Major depressive disorder. - Molecular Weight :413.47
- Boiling Point :844.2±65.0°C(Predicted)
- Purity :≥98% by HPLC
Molecular Formula : C18H31N5O6 Canonical SMILES : CC(C(C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)N)N)O InChI : InChI=1S/C18H31N5O6/c1-9(24)13(19)18(29)23-8-4-6-12(23)17(28)22-7-3-5-11(22)16(27)21-14(10(2)25)15(20)26/h9-14,24-25H,3-8,19H2,1-2H3,(H2,20,26)(H,21,27)/t9-,10-,11+,12+,13+,14+/m1/s1 InChIKey : GIBQQARAXHVEGD-BSOLPCOYSA-N Solubility : Soluble in DMF (25 mg/ml), DMSO (15 mg/ml), Ethanol (10 mg/ml) Appearance : White to Tan Powder Application : Rapastinel is a brain penetrable tetrapeptide and could be a partial agonist of NMDA receptor. Storage : Store at -20°C Synonyms : GLYX-13; GLYX 13; GLYX13; BV-102; BV102; BV 102; TPPT-amide; Rapastinel; UNII-6A1X56B95E; GLYX-13 trifluoroacetate; TPPT-amide trifluoroacetate
More details are to be found here
Detailed information on the suppliers of
Rapastinel
|
Properties:
... more properties and specification on Rapastinel
|
|
Privileged suppliers
Last update 2024-04-26
|